Nakazawa H K, Handa S, Nakamura Y, Oyanagi H, Hasegawa M, Ishikawa N, Ozaki O, Ito K
Int J Cardiol. 1987 Jul;16(1):47-55. doi: 10.1016/0167-5273(87)90269-5.
We performed rhythm conversion on 33 euthyroid patients with post-thyrotoxic atrial fibrillation who do not revert spontaneously to sinus rhythm from atrial fibrillation. The duration of atrial fibrillation ranged from 9 to 59 months (mean 25 +/- 14). The protocol of rhythm conversion was to first attempt pharmacological conversion with disopyramide and then to perform electrical cardioversion on the non-converters. Of 33 patients, 25 were converted to sinus rhythm (6 by disopyramide and 19 by electrical cardioversion), resulting in 8 non-converters. However, it was later discovered that cardioversion had been applied to 4 of the 8 non-converters when these patients had had a recurrence of thyrotoxicosis. These 4 patients were subjected to a second electrical cardioversion after attaining the euthyroid state. Sinus rhythm was restored in all 4 patients, giving a cardioversion rate of 88%. The sinus rhythm was maintained in 25 of the total 29 converters (86%) at the time of follow-up (10-68 months, mean 35 +/- 19 months). Our studies suggest that cardioversion should be encouraged for thyrotoxic atrial fibrillation, even if the duration of atrial fibrillation is long-standing, since there is excellent maintenance of sinus rhythm and even delayed application of cardioversion may improve its success rate.
我们对33例甲状腺功能正常但患有甲状腺毒症后房颤且房颤不能自发转为窦性心律的患者进行了节律转复。房颤持续时间为9至59个月(平均25±14个月)。节律转复方案是首先尝试用丙吡胺进行药物转复,然后对未转复者进行电转复。33例患者中,25例转为窦性心律(6例通过丙吡胺转复,19例通过电转复),8例未转复。然而,后来发现,在这8例未转复者中有4例在甲状腺毒症复发时接受了电转复。这4例患者在甲状腺功能恢复正常后接受了第二次电转复。所有4例患者均恢复了窦性心律,转复率为88%。在随访时(10 - 68个月,平均35±19个月),29例转复者中有25例(86%)维持窦性心律。我们的研究表明,对于甲状腺毒症性房颤,即使房颤持续时间较长,也应鼓励进行转复,因为窦性心律维持良好,甚至延迟进行转复也可能提高成功率。